Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion type Assertion NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_head.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion description "[Our data show further that activation of ADAMs results in discrete cellular responses; whereas GPCR agonists promote activation of the Ras/MAPK pathway and cell proliferation via the EGFR in fibroblasts and ACHN cells, EGFR transactivation pathways regulate activation of the survival mediator Akt/protein kinase B and the susceptibility of fibroblasts and TccSup bladder carcinoma cells to proapoptotic signals such as serum deprivation, death receptor stimulation, and the chemotherapeutic drug doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_provenance.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion evidence source_evidence_literature NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_provenance.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion SIO_000772 15337756 NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_provenance.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion wasDerivedFrom befree-2016 NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_provenance.
- NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_assertion wasGeneratedBy ECO_0000203 NP457957.RA9EffIQd6LCBBW1ZrASogI5sh6iquPxL8AcN6X5hvwVE130_provenance.